关注
Josh Woolley
Josh Woolley
在 ucsf.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ...
Focus 21 (3), 315-328, 2023
6402023
The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early …
JD Woolley, BK Khan, NK Murthy, BL Miller, KP Rankin
The Journal of clinical psychiatry 72 (2), 4437, 2011
5302011
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia
JD Woolley, ML Gorno-Tempini, WW Seeley, K Rankin, SS Lee, ...
Neurology 69 (14), 1424-1433, 2007
2932007
Cognitive and behavioral profile in a case of right anterior temporal lobe neurodegeneration
ML Gorno-Tempini, KP Rankin, JD Woolley, HJ Rosen, L Phengrasamy, ...
Cortex 40 (4-5), 631-644, 2004
2022004
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
BT Anderson, A Danforth, R Daroff, C Stauffer, E Ekman, G Agin-Liebes, ...
EClinicalMedicine 27, 2020
1652020
Oxytocin administration enhances controlled social cognition in patients with schizophrenia
JD Woolley, B Chuang, O Lam, W Lai, A O’Donovan, KP Rankin, ...
Psychoneuroendocrinology 47, 116-125, 2014
1302014
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
JS Aday, BD Heifets, SD Pratscher, E Bradley, R Rosen, JD Woolley
Psychopharmacology 239 (6), 1989-2010, 2022
1162022
Psychedelic-assisted group therapy: a systematic review
A Trope, BT Anderson, AR Hooker, G Glick, C Stauffer, JD Woolley
Journal of psychoactive drugs 51 (2), 174-188, 2019
1042019
Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial
CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ...
Jama 330 (9), 843-853, 2023
1022023
Intranasal oxytocin selectively modulates social perception, craving, and approach behavior in subjects with alcohol use disorder
JM Mitchell, PA Arcuni, D Weinstein, JD Woolley
Journal of addiction medicine 10 (3), 182-189, 2016
922016
Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward
ER Bradley, JD Woolley
Neuroscience & Biobehavioral Reviews 80, 36-56, 2017
872017
Nucleus accumbens opioids regulate flavor-based preferences in food consumption
JD Woolley, BS Lee, HL Fields
Neuroscience 143 (1), 309-317, 2006
832006
Intranasal oxytocin may improve high-level social cognition in schizophrenia, but not social cognition or neurocognition in general: a multilevel bayesian meta-analysis
PC Bürkner, DR Williams, TC Simmons, JD Woolley
Schizophrenia Bulletin 43 (6), 1291-1303, 2017
802017
Frontotemporal dementia and mania
JD Woolley, MR Wilson, E Hung, ML Gorno-Tempini, BL Miller, J Shim
American Journal of Psychiatry 164 (12), 1811-1816, 2007
792007
Intranasal oxytocin mechanisms can be better understood, but its effects on social cognition and behavior are not to be sniffed at
DS Quintana, JD Woolley
Biol Psychiatry 79 (8), e49-e50, 2016
602016
Endogenous dopaminergic modulation of the lamprey spinal locomotor network
E Svensson, J Woolley, M Wikström, S Grillner
Brain research 970 (1-2), 1-8, 2003
582003
A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder
CS Stauffer, V Musinipally, A Suen, KL Lynch, B Shapiro, JD Woolley
Addiction research & theory 24 (6), 490-498, 2016
562016
Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report.
M Fisher, M Nahum, E Howard, A Rowlands, B Brandrett, A Kermott, ...
Psychiatric rehabilitation journal 40 (1), 21, 2017
542017
Endogenous opioids encode relative taste preference
SA Taha, E Norsted, LS Lee, PD Lang, BS Lee, JD Woolley, HL Fields
European Journal of Neuroscience 24 (4), 1220-1226, 2006
522006
Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience
CS Stauffer, BT Anderson, KM Ortigo, J Woolley
ACS pharmacology & translational science 4 (2), 526-532, 2020
492020
系统目前无法执行此操作,请稍后再试。
文章 1–20